Biologic, histologic and densitometric effects of oral risedronate on bone in patients with multiple myeloma
- 28 February 1994
- Vol. 15 (1), 41-49
- https://doi.org/10.1016/8756-3282(94)90890-7
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assayJournal of Bone and Mineral Research, 1992
- Effects of five daily 1 h infusions of alendronate in paget's disease of boneJournal of Bone and Mineral Research, 1992
- Relationship between the number of resorbing cells and the amount resorbed in metabolic bone disordersJournal of Bone and Mineral Research, 1991
- Treatment of paget's disease with intermittent low-dose infusions of disodium pamidronate (APD)Journal of Bone and Mineral Research, 1990
- LONG-TERM EFFECTS OF PARENTERAL DICHLOROMETHYLENE BISPHOSPHONATE (CL2MBP) ON BONE DISEASE OF MYELOMA PATIENTS TREATED WITH CHEMOTHERAPYHematological Oncology, 1990
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987
- Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss.Journal of Clinical Investigation, 1983
- Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple MyelomaMetabolic Bone Disease and Related Research, 1982
- Effects of Dichloromethylene Diphosphonate on Skeletal Mobilization of Calcium in Multiple MyelomaNew England Journal of Medicine, 1980
- Seasonal Changes in Human Plasma Levels of 25-Hydroxyvitamin DNature, 1974